Navigation Links
High Cholesterol in Youth Boosts Heart Risk In Middle Age
Date:8/2/2010

By Steven Reinberg
HealthDay Reporter

MONDAY, August 2 (HealthDay News) -- Young adults whose cholesterol levels are even slightly higher than normal are at greater risk of developing artery-clogging calcium deposits later in life, which can trigger hardening of the arteries leading to heart disease, a new study suggests.

This conclusion runs counter to the common assumption that modestly high cholesterol levels are nothing to worry about in young adults. Equally important, it argues that people need to start eating healthy and exercising early to prevent heart disease, the researchers say.

"You can't just ignore your cholesterol levels until you get into middle age. You have to be thinking about them and having a healthy diet and exercise regimen even early in life when you are at low risk for heart attacks," said lead researcher Dr. Mark J. Pletcher, an assistant professor in the department of epidemiology and biostatistics at the University of California, San Francisco.

Pletcher recommends diet and exercise as a way to control cholesterol, because the use of cholesterol-lowering drugs such as statins in young adults is controversial. People should start having their cholesterol checked when they are in their 20s, he said, and they should start a healthy diet and exercise program at the same time.

The report is published in the Aug. 2 issue of the Annals of Internal Medicine.

For the study, Pletcher's team collected data on almost 3,300 men and women 18 to 30 years old participating in the CARDIA (Coronary Artery Risk Development in Young Adults) Study. Participants in the prospective study -- recruited from four different U.S. cities -- were comprised of black and white men and women who were healthy when they enrolled. Over a period of 20 years, they had their low- and high-density lipoprotein (LDL and HDL) cholesterol and triglycerides levels measured repeatedly.

After 20 years, the researchers performed scans looking at coronary artery calcium, which is a measure of calcium deposits in the coronary arteries. The average age at the time of the scan was 45. Coronary calcium deposits -- a risk factor for heart disease -- were present in 17 percent of the participants, or nearly one in five.

People whose "bad" cholesterol (LDL cholesterol) was high when they were in their 20s were more likely to have calcium lining their coronary arteries after age 35, the researchers found. In a subset of participants without abnormal blood fat levels who were not taking lipid-lowering medicine, low levels of good HDL cholesterol were also associated with a higher risk of calcifications.

For example, 44 percent of those with an average LDL of more than 160 milligrams per deciliter (mg/dL) when they were young had plaque buildup in their coronary arteries 20 years later, compared with 8 percent of those whose LDL levels were less than 70 mg/dL, Pletcher noted.

Even a modest rise in LDL, as low as 100-129 mg/dL, was associated with a higher risk of atherosclerosis, the researchers said. Sixty-five percent of the young adults had LDL levels greater than 100 mg/dL, they added.

The study had some limitations, the researchers noted in the Annals of Internal Medicine. "Coronary calcium, although a strong predictor of future coronary heart disease, is not a clinical outcome," they wrote.

The researchers also wrote that "safety concerns [about cholesterol-lowering treatments] are rightly magnified when starting treatment early in life is considered." The findings, they said, "cannot provide evidence for the effectiveness or safety" of using cholesterol-lowering drugs, such as statins, during young adulthood, although they added that could be an area for further investigation.

"It is an active area of debate," Pletcher said, adding that new guidelines are expected next year that will consider the use of statins in young adults.

Although drug therapy might be useful, Pletcher added, "there is no firm evidence that treating people with statins during young adulthood is overall beneficial, because it would require treating people for 30 to 50 years before any benefit in terms of heart attack prevention would occur."

Dr. Gregg C. Fonarow, a professor, medicine and director of the Ahmanson-UCLA Cardiomyopathy Center at the University of California, Los Angeles said that "it has been very well established that atherosclerosis begins in childhood and progresses during adolescence and young adulthood, resulting in more advanced lesions in middle-aged and older adults."

The atherosclerosis disease process begins with lipids accumulating in the artery wall and ultimately may result in more advanced lesions that rupture, leading to heart attacks, he said.

"These results and prior studies lend support for the public health strategy of beginning risk-factor control in youth and continuing it life-long through improved cardiovascular health behaviors," Fonarow said.

In terms of what can be done, Fonarow said that "lifestyle changes are the mainstay of lipid and other cardiovascular risk factor modification in youth."

Fonarow added that cholesterol-lowering drugs should be used only in young people who have very high cholesterol levels.

"According to current guidelines, statins or other cholesterol lowering medications should generally be reserved for pediatric patients with very high LDL levels, with careful assessment of the risks and benefits of drug treatment," he added.

More information

For more information on cholesterol, visit the U.S. National Library of Medicine.

SOURCES: Mark J. Pletcher, M.D., M.P.H., assistant professor, department of epidemiology and biostatistics, University of California, San Francisco; Gregg C. Fonarow, M.D., professor, medicine, and director, Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles; Aug. 2, 2010, Annals of Internal Medicine.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. No firm conclusions about HDL cholesterol can be drawn from JUPITER sub-analysis
2. Some on Statins May Not Need Boost in Good Cholesterol
3. New links between cholesterol and depression in the elderly
4. Screening Guidelines Miss Many Kids With High Cholesterol
5. Good HDL Cholesterol Now Tied to Lower Cancer Risk
6. U of M study: Monitoring cholesterol increases life expectancy
7. Eating Nuts May Help Cholesterol Levels
8. Children may be able to eat before cholesterol test, study shows
9. Watch Your Cholesterol, Your Blood Pressure ... and This Enzyme?
10. Cholesterol Drugs May Slow MS
11. Should Cholesterol Drugs Be Used By Those Without High Cholesterol?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
High Cholesterol in Youth Boosts Heart Risk In Middle Age
(Date:4/28/2017)... york (PRWEB) , ... April 28, 2017 , ... ... to announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under ... and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April 30 to ... Care Medicine will host industry leaders for the annual spring Convention & Expo, ... the industry adapt to the issues currently affecting urgent care and on-demand healthcare. ...
(Date:4/28/2017)... ... 2017 , ... Bill Howe started his sewer and drain company in 1980 ... joined the team, the Bill Howe brand was born and they began cultivating their ... back to the San Diego community in which they worked, lived and were raising ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... CA (PRWEB) , ... April 28, 2017 , ... NuevaCare, ... cities as diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce information ... interested persons to bookmark and read organized content on topics such as home care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it will be participating in the Deutsche Bank Securities ... in Boston, Massachusetts on Wednesday, ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .  The webcast will ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
Breaking Medicine Technology: